Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets ...

ALK (ALKB:DC / OMX: ALK B) today announced that its European regulatory filing for ACARIZAX® (house dust mite sublingual allergy immunotherapy ...

NANJING, China, Dec. 4, 2024 /PRNewswire/ -- On November 2, 2024, Simcere Pharmaceutical announced that Sanbexin ® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets ...

BNT23001, a sublingual formulation of cladribine, will be tested in a pilot clinical trial in 2025 comparing it to MS ...

China’s National Medical Products Administration (NMPA) granted new approvals to several Chinese biopharmaceuticals this week, including expanding indications of four different cancer drugs and ...

PNN Ahmedabad Gujarat [India]7 Troikaa Pharma announced that it has launched its Zolpidem Sublingual Spray 385 wv for the ...

Simcere Pharmaceutical Group Limited (HK:2096) has released an update. Simcere Pharmaceutical Group Limited has received approval from China’s ...

The AGA has provided expert advice regarding the diagnosis and management of cyclic vomiting syndrome. Read more!

VANCOUVER, BC / ACCESSWIRE / December 2, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC ...

Do you find yourself sneezing, itching or battling watery eyes as the seasons change? If so, you may have a pollen ...